<DOC>
	<DOCNO>NCT02810327</DOCNO>
	<brief_summary>The goal study well understand Alpha-1 genotype MZ ( PiMZ ) individual develop chronic obstructive pulmonary disease ( COPD ) others . This study examine portion Alpha-1 gene routinely test determine whether change gene correlate development progression COPD . Participation involve respond questionnaire lung health history , perform at-home finger stick obtain blood spot use test kit mail . The blood provide used genetic test correlation result COPD history . Participants receive result access genetic counseling conclusion study .</brief_summary>
	<brief_title>Alpha-1 Carrier Genomics Study</brief_title>
	<detailed_description>Alpha-1 Antitrypsin Deficiency ( AATD , Alpha-1 ) best establish genetic risk factor chronic obstructive pulmonary disease ( COPD ) liver disease . Clinical presentation heterogeneous genotypic population alpha-1 antitrypsin deficiency ( AATD ) genetic variation Alpha-1 gene incompletely study . Rare gene alteration predispose COPD risk classic AATD individual without classic homozygous deficiency genotype study important understanding , test treat at-risk population . Investigators hypothesize SERPINA1 gene sequence find important sequence variation previously assess MZ individual COPD compare age , race , sex , AAT level smoking status match MZ individual COPD . The Alpha-1 Carrier Genomics study pilot study enroll 150 MZ individual . COPD+ COPD- individual match age , sex , race smoke history . Presence severity COPD assess COPD severity score questionnaire . Participants mail test kit obtain return blood sample finger stick purpose SERPINA1 gene sequence . Gene sequence identify , present , genomic signature may correlate COPD cohort . Participants receive result access genetic counseling conclusion study .</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin Deficiency</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin</mesh_term>
	<mesh_term>Protein C Inhibitor</mesh_term>
	<criteria>1 . Signed informed consent 2 . PiMZ individual fall low quartile AAT level . 1 . Age &lt; 18 year 2 . Known homozygous compound heterozygous classic severe AATD ( e.g . PiSZ , ZZ , Znull )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Alpha-1 antitrypsin deficiency</keyword>
	<keyword>AATD</keyword>
	<keyword>Alpha-1</keyword>
	<keyword>SERPINA1</keyword>
	<keyword>MZ</keyword>
	<keyword>Carrier</keyword>
	<keyword>Heterozygote</keyword>
	<keyword>Smoking</keyword>
	<keyword>COPD</keyword>
	<keyword>Emphysema</keyword>
	<keyword>Sequencing</keyword>
</DOC>